Hepatitis C- and HIV-induced porphyria cutanea tarda

American Journal of Case Reports

Volumn 15, Issue , 2014, Pages 35-40

  Quansah, Raphael ^a   Cooper, Chad J ^a   Said, Sarmad ^a   Bizet, Jorge ^a   Paez, David ^a   Hernandez, German T ^a  

^a Texas Tech University Health Sciences Center El Paso   (United States)

Author keywords

Chloroquine; Hepatitis C complications; HIV; Phlebotomy; Porphyria Cutanea Tarda

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CEFTRIAXONE; COTRIMOXAZOLE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; FERRITIN; IRON; LOPINAVIR PLUS RITONAVIR; PIPERACILLIN PLUS TAZOBACTAM; PORPHYRIN DERIVATIVE; TRANSFERRIN; VANCOMYCIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ANTIBIOTIC THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CULTURE; CASE REPORT; CD3 LYMPHOCYTE COUNT; CD4 LYMPHOCYTE COUNT; CD8 LYMPHOCYTE COUNT; CELLULITIS; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FERRITIN BLOOD LEVEL; HAND EDEMA; HAND PAIN; HEPATITIS C; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPONATREMIA; IRON BINDING CAPACITY; IRON BLOOD LEVEL; KLEBSIELLA PNEUMONIAE; LYMPHOCYTE COUNT; MALE; MEDICAL RECORD REVIEW; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; OSTEOMYELITIS; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PHLEBOTOMY; PHYSICAL EXAMINATION; PIGMENT DISORDER; POLYMERASE CHAIN REACTION; PORPHYRIA CUTANEA TARDA; PROPHYLAXIS; PROTEIN BLOOD LEVEL; SEROLOGY; SKIN ABSCESS; SKIN DEFECT; SKIN EXAMINATION; SKIN PROTECTION; TRANSFERRIN BLOOD LEVEL; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; URINALYSIS; WESTERN BLOTTING;

EID: 84892750493     PISSN: None     EISSN: 19415923     Source Type: Journal    
DOI: 10.12659/AJCR.889955     Document Type: Article

References (15)

1. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R: Prevalence of Hepatitis C virus infection in porphyria cutanea tarda. systematic review and a meta-analysis. J Hepatol, 2003; 39(4): 620-27
2. Kushner JP, Barbuto AJ, Lee GR: An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen activity. J Clin Invest, 1976; 58(5): 1089-97
3. Egger NG, Goeger DE, Payne DA et al: Porphyria cutanea tarda multiplicity of risk factor including HFE mutations, hepatitis C and inherited uroprophyrinogen decarboxylase deficiency. Dig Dis Sci, 2002; 47(2): 419-26
4. Tarwater K, Misra S, Misra M: Type I (sporadic) porphyria cutanea tarda in a hemodialysis patient: A case report. Hemodial Int, 2008; 12(2): S38-42
5. Fargion S, Fracanzani AL: Prevalence of Hepatitis C virus infection in porphyria cutanea tarda. J Hepatol, 2003; 399(4): 635-38
6. Frank J, Poblete-Gutierrez P: Porphyria cutanea tarda-when skin meets liver. Best Pract Res Clin Gastroenterol, 2010; 24(5): 735-45
7. Sarkany RPE: The management of porphyria cutanea tarda. Clin Exp Dermatol, 2001; 26(3): 225-32
8. Köstler E, Wollina U: Therapy of porphyria cutanea tarda. Expert Opin Pharacother, 2005; 6(3): 377-83
9. Elder GH: Porphyria Cutanea Tarda and related disorders. In: The Porphyria Handbook; Kadish K, Smith K (eds.), Elsevier Science, San Diego 2003; 14: 67
10. Nagy Z et al: Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients. Liver International, 2004; 24(1): 16-20
11. Lacour JP, Bodokh I, Castanet J et al: Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol, 1993; 128: 121-23
12. Azim J, McCurdy H, Moseley RH: Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C. World J Gastroenterol, 2008; 14(38): 5913-15
13. O'Connor WJ, Murphy GM, Darby C et al: Porphyrin abnormalities in acquired immunodeficiency syndrome. Arch Dermatol, 1996; 132: 1443-47
14. Reynaud P, Goodfellow K, Svec F: Porphyria cutanea tarda as initial presentation of the acquired immunodeficiency syndrome in two patients. J Infect Dis, 1990; 161: 1032-33
15. Caballes FR, Sendi H, Bonkovsky HL: Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver Int, 2012; 32(6): 880-93